von Mehren M, Benjamin RS, Bui MM et al. . NCCN Clinical Practice Guidelines in Oncology: Soft Tissue Sarcoma. Version 2, 2012. Available at NCCN.org. Accessed June 26, 2012.
Pollack A, Zagars GK, Goswitz MS et al. . Preoperative vs. postoperative radiotherapy in the treatment of soft tissue sarcomas: a matter of presentation. Int J Radiat Oncol Biol Phys 1998;42:563–572.
Hohenberger P, Schwarzbach MH. Management of locally recurrent soft tissue sarcoma after prior surgery and radiation therapy. Recent Results Cancer Res 2009;179:271–283.
Bokemeyer C, Franzke A, Hartmann JT et al. . A phase I/II study of sequential, dose-escalated, high dose ifosfamide plus doxorubicin with peripheral blood stem cell support for the treatment of patients with advanced soft tissue sarcomas. Cancer 1997;80:1221–1227.
Wunder JS, Nielsen TO, Maki RG et al. . Opportunities for improving the therapeutic ratio for patients with sarcoma. Lancet Oncol 2007;8:513–524.
Suppiah R, Wood L, Elson P et al. . Phase I/II study of docetaxel, ifosfamide, and doxorubicin in advanced, recurrent, or metastatic soft tissue sarcoma (STS). Invest New Drugs 2006;24:509–514.
Watanabe T, Tsuda M, Tanaka S et al. . Adaptor protein Crk induces Src-dependent activation of p38 MAPK in regulation of synovial sarcoma cell proliferation. Mol Cancer Res 2009;7:1582–1592.
Mortenson MM, Khatri VP, Bennett JJ et al. . Total mesorectal excision and pelvic node dissection for rectal cancer: an appraisal. Surg Oncol Clin N Am 2007;16:177–197.